BRENNEN

Industries / Frontier science / Synthetic biology

Scale-up

This is the work of getting from a strain that performs in a flask to a plant that makes tonnes, and of paying for the plant.

7

Milestones achieved, from 2002 to 2025.

2

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 2002

    A fermented polymer at scale

    Cargill Dow, a joint venture of Cargill and Dow Chemical, started up a plant at Blair, Nebraska, that ferments sugar from maize into lactic acid and joins the acid into chains to make polylactide, a plastic. The trade journal Plasteurope reported the start-up in April 2002 as the company's first commercial-scale plant for the polymer. Its present owner gives the nameplate capacity as 150,000 metric tons a year and says the world's largest lactic acid plant was built beside it in 2003.

    plasteurope.comnatureworksllc.com

    Credit

    Cargill Dow, now NatureWorks, jointly owned by Cargill and PTT Global Chemical

  2. 2017

    An algae oil company fails

    TerraVia, which had been built to sell algae-derived oil as fuel and changed course in 2016 towards food, feed and personal care, filed for Chapter 11 bankruptcy protection in August 2017. The ingredients company Corbion put in a stalking-horse bid of USD 20 million, an opening offer that sets the floor for an auction of the assets.

    Lessonowning plants did not save the company; the products reached market too slowly for the capital already spent.

    fooddive.com

    Credit

    TerraVia and Corbion

  3. 2020

    A public institute for scale-up

    The US Department of Defense named BioMADE as its Bioindustrial Manufacturing Innovation Institute in October 2020. BioMADE opened its first call for projects in April 2021 and now reports more than 300 members across 40 states. Its Pilot Plant Network is meant to give companies shared pilot-scale equipment that no one of them has to build alone.

    biomade.orgburnsmcd.com

    Credit

    US Department of Defense and BioMADE

  4. 2022

    An order makes it policy

    The US president signed Executive Order 14081 on 12 September 2022, directing agencies to expand domestic biomanufacturing capacity and to treat the bioeconomy as a matter of national policy.

    federalregister.gov

    Credit

    the White House

  5. 2022

    A free list of fermenters

    The company Synonym published Capacitor in November 2022 and described it as the first comprehensive, free database of microbial fermentation facilities worldwide. Its first report, drawn from that database, concluded that the network of large-scale plant the industry's products would need "doesn't yet exist".

    synonym.bio

    Credit

    Synonym

  6. 2023

    Amyris files for bankruptcy

    Amyris, which its own announcement said had been founded twenty years earlier to make ingredients by fermentation, began voluntary Chapter 11 proceedings in Delaware on 9 August 2023 with a commitment of USD 190 million in debtor-in-possession financing, a loan that keeps a bankrupt company trading, from an entity tied to its existing lender Foris Ventures. It said it would sell its consumer brands and return to research and the scale-up of ingredients.

    Lessonthe plants kept running while the company around them failed, so the risk at this stage sits in the balance sheet rather than the fermenter.

    biospace.com

    Credit

    Amyris

  7. 2025

    A commission names a figure

    The National Security Commission on Emerging Biotechnology, which Congress created in 2022, published its final report on 8 April 2025. The Congressional Research Service records 49 recommendations across six priority areas and a recommendation that the United States invest a minimum of USD 15 billion over five years in emerging biotechnology.

    congress.govbiotech.senate.gov

    Credit

    National Security Commission on Emerging Biotechnology

Watch for

  1. A shared plant in Minnesota

    BioMADE's first demonstration-scale site, at Maple Grove, Minnesota, is to convert a 122,000 square foot building into a plant handling fermentation and downstream processing from laboratory scale up to 25,000 litres, run like a contract manufacturer so that companies can prove a process on shared equipment. Burns & McDonnell was named engineer-procure-construct provider on 22 April 2026.

    Achieved whenthe plant runs a paying customer's process at 25,000 litres and a party outside both organisations reports it.

    burnsmcd.com

    Claimed by

    BioMADE and Burns & McDonnell, April 2026

  2. A fourth line in Brazil

    Amyris bought Ingredion's 31% share of their RealSweet joint venture in May 2025 to take full ownership of its fermentation plant at Barra Bonita in Brazil, and said a fourth production line would be running in early 2026. On 16 March 2026 trade press reported that the line was built, in a two-by-80-cubic-metre configuration beside the site's three larger lines, and quoted the company saying it was in operation.

    Achieved whena report from outside the company, or an audited filing, shows the line producing at that scale.

    amyris.combiofuelsdigest.comtheplantbasemag.com

    Claimed by

    Amyris, March 2026

Open

  1. 01

    Promised plants against running plants

    an open register of every announced fermentation plant or capacity expansion since 2015, recording the date of the announcement, the capacity promised in litres or tonnes, the promised start, and the money named, matched against what the site is doing now, with the share of promises kept published by year.

    The brief
    Credit · unclaimed
  2. 02

    One model, many papers

    published cost studies of fermentation products re-implemented in one open simulator, first with each paper's own assumptions, then with every product recomputed on one common set of financial parameters, so that the figures can be read side by side.

    The brief
    Credit · unclaimed

Open 01 · the brief

Promised plants against running plants

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

an open register of every announced fermentation plant or capacity expansion since 2015, recording the date of the announcement, the capacity promised in litres or tonnes, the promised start, and the money named, matched against what the site is doing now, with the share of promises kept published by year.

Why it is still open

Capacitor, published free in November 2022, records facilities rather than the history of what was promised when, and as of November 2026 the capacitor.bio address presents Synonym's commercial matching service rather than a public directory. Trade press reports announcements one at a time and rarely returns to them. Liberation Bioindustries' plant at Richmond, Indiana, designed for 600,000 litres, was reported in January 2026 as nearing completion with production expected during the year, and no public record says what happened next.

synonym.biovegconomist.com

Built with what exists

company press releases and investor filings, local planning and permit records, a model that reads filings and pulls out dates and figures, and a public spreadsheet published with its code.

  1. First step

    take 20 announcements from 2021 and 2022 and record, with a source for each, what the site is doing today.

  2. Done looks like

    100 announcements recorded with both the promise and the outcome, each backed by two sources, and the share delivered within a year of the promised date published for each year since 2015.

Open 02 · the brief

One model, many papers

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

published cost studies of fermentation products re-implemented in one open simulator, first with each paper's own assumptions, then with every product recomputed on one common set of financial parameters, so that the figures can be read side by side.

Why it is still open

the Good Food Institute's meta-analysis of June 2025 found 48 publications in scope for fermentation-derived food ingredients and 35 of them, holding 55 models, good enough to use, and reported that limited coverage of products and processes obscures the understanding of progress because cost estimates and process metrics vary widely. Papers in the field make the same point about assumptions needing to match before results can be compared, and no public repository reproduces the models. The simulator and a public model repository already exist, which is what makes this a job rather than a research problem: BioSTEAM's Bioindustrial-Park repository has held biorefinery models and their results under an MIT licence since 2020 and was last updated in November 2026, but it holds the configurations its own developers published, not the cost studies of other groups.

gfi.orgapi.github.comcabbi.bio

Built with what exists

BioSTEAM, an open-source package for biorefinery simulation and cost analysis published since 2019; the papers' own supplementary data; and a coding agent that tests its own work.

  1. First step

    choose five open-access cost studies, record every parameter each one gives, and publish the list of what is missing from each.

  2. Done looks like

    25 papers re-implemented in one public repository, a table giving each product's recomputed cost on common parameters, and a count of the papers that cannot be reproduced from what they state.